comparemela.com

Latest Breaking News On - Heather savelle - Page 10 : comparemela.com

SCYNEXIS, Inc. Enters Into Worldwide Agreement With Waterstone Pharmaceutical for the Development and Commercialization of SCY-635 for Viral Diseases

SCYNEXIS, Inc. Enters Into Worldwide Agreement With Waterstone Pharmaceutical for the Development and Commercialization of SCY-635 for Viral Diseases
mareeg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mareeg.com Daily Mail and Mail on Sunday newspapers.

China
Boston
Massachusetts
United-states
Yvesj-ribeill
Heather-savelle
Exchange-commission
Macdougall-biomedical-communications
Waterstone
Waterstone-pharmaceutical
Scynexis-inc
Nasdaq

PR News | On the Move: TScan Therapeutics Taps Savelle for VP-IR Post

PR News | On the Move: TScan Therapeutics Taps Savelle for VP-IR Post
odwyerpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from odwyerpr.com Daily Mail and Mail on Sunday newspapers.

Peter-foley
David-southwell
Heather-savelle
Lydia-blandon
Macdougall-biomedical-communications
Argot-partners
Macdougall-biomedical
Rebecca-silver
Seriesd-fundraise

Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced.

Australia
Japan
United-states
New-zealand
Massachusetts
Cambridge
Cambridgeshire
United-kingdom
South-korea
Canada
Republic-of-korea
Douglase-onsi

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Heather-savelle
Prnewswire-calyxt-inc
Calyxt-inc
Nasdaq
Annual-global-investment-conference
Media-contact
Investor-relations-contact

Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation

/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.

Australia
Japan
United-states
Cambridge
Cambridgeshire
United-kingdom
New-zealand
South-korea
Republic-of-korea
Australian
Douglase-onsi
Heather-savelle

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.